Society for Experimental Biology & Medicine

Meetings

The Society for Experimental Biology and Medicine holds an annual member's meeting in conjunction with the EB meetings each year.

SEBM at EB 2010

Anaheim, California

On Sunday, April 25th, please join us

at the SEBM Member’s Socializer and Awards Presentation 5:30 – 7:15 PM
Grand Ballroom Salon CD, Anaheim Marriott Hotel

We will have a ceremony for the following awards:
2009 Best Paper
2010 Young Investigators
Distinguished Scientists (inaugural group)

Saturday, April 24th Council/Member’s Business Meeting at 12:30 p.m.

Grand Ballroom Salon B, Anaheim Marriott Hotel

Sunday, April 25th, Ballroom B Convention Center 3:15 – 5:30 p.m.

SEBM Symposium: “Evolving from reductionism to holism: The future is systems medicine” Chaired by: Susan Mulroney and Howard Federoff

SEBM Symposium at EB 2009

The Co-morbidity of Stress and Disease: Effects of Chronic Stress on Metabolism, Cardiovascular Disease and Behavior

Chairs: Susan E. Mulroney, Georgetown University and Yvette Tache, UCLA

Papers from this symposium will be published in an upcoming issue of Experimental Biology and Medicine.

"Corticotropin-Releasing Hormone and Stress-Related Disease"
Yvette Tache, PhD, David Geffen School of Medicine, UCLA

"Chronic stress exacerbates development of metabolic syndrome via an NPY-mediated mechanism"
Zofia Zukowska, MD, PhD, Georgetown University Medical Center

"Stress and anxiety"
Annika Thorsell, PhD, Staff Scientist, NIH/NIAA

"Adaptation to Extreme Stress: Neuropeptide Y, PTSD, and Long-term Health Consequences"
Ann Rasmusson, MD, Yale University and VA National Center for PTSD

SEBM Symposium at EB 2008, San Diego, California

"Progress in Pharmacogenomics and Its Promise for Medicine"

Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina

"Implications of Pharmocogenomics for Drug Development"
Randal J. Kirk, J.D., CEO, Third Security, LLC

"Implications of pharmacogenomics requiring regulatory agency"
Mary K. Pendergast, J.D., L.L.M, Pendergast Consulting, Washington, DC

"Applications of pharmacogenomics in the use of psychotropic drugs"
Meeta Patnaik,M.D., Senior Vice President, Predictive Diagnostics Development for PGxHealth

"Pharmaco-proteomic approaches to understanding the mechanisms and side effects of sickle cell drug therapy"
Steven R. Goodman, PhD, Editor-in-Chief, Experimental Biology and Medicine, University of Texas at Dallas

SEBM Symposium at EB 2007, Washington D.C.

"Nanotechnology, Biology, and Medicine in SEBM's Second Century"

SEBM gratefully acknowledges Genentech for their donation in support of this symposium.

Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina

"Engineered viruses for biomedical science"
M.G. Finn, The Scripps Research Institute

"Biological structures of mesosclae systems"
Stephen G. Sligar, University of Illinois

Experimental biology and medicine" in SEBM's second century
Steven R. Goodman, University of Texas at Dallas

SEBM Symposium at EB 2006, San Francisco

"The Role of Modern Biology and Medicine in Drug Development in Academia and Industry"

Chairpersons: Charles A.Blake, University of South Carollina and Kenneth L. Barker, State University of New York, Syracuse

Ted W. Love, Nuvelo, Inc.
"How to Attract the Best and Brightest to Benefit Drug Development"

Timothy P. Clackson, ARIAD Pharmaceuticals, Inc
"Translational Research In Academia and Industry"

Scott P. Kennedy, Pfizer Gobal R&D
"Effective Partnering of Academic and Physician Scientists with the Pharmaceutical Drug Development Industry"

Discussion Leader: Burton E. Sobel, University of Vermont

SEBM Symposium at EB 2005, San Diego

"Physiological Proteomics"

Chairpersons: Charles A. Blake and Steven R. Goodman

Charles A. Blake, University of South Carolina
"The proteomics of the anterior pituitary gland"

Steven R. Goodman, University of of Texas at Dallas
"The proteomics of sickle cell disease"

Carlos Gusti Gartner, Harvard Medical School
"Catch-and-release (CAR) reagents: new tools for broadscale analysis of the proteome"

Mark W. Duncan, Univeristy of Colorado Health Sciences Center
"Clinical applications of proteomics"

SEBM Symposium at EB 2004, Washington, DC

Support for this symposium has been provided by AstraZeneca

"Non-hemostatic Physiological Effects of Hemostatis-related Components"

Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York

David J. Loskutoff, Scripps Research Institute
"Role of PAI-1 in Cell Adhesion and Detachment"

Daniel A. Lawrence, American Red Cross Holland Laboratories
"Fibrinolytic Molecules and Neural Function"

Jay L. Degen, Children's Hospital Research Foundation, Cincinnati
"Dissociation of the Hemostatic and Inflammatory Roles of Fibrinogen"

Jerry Ware, Scripps Clinic
"Septins in Platelets and Neural Tissue"

SEBM Symposium at EB 2003, San Diego

Support for this symposium has been provided by Merck & Co and AstraZeneca.

"Career Planning for Experimental Biology, Biomedical and Physician Scientists"

Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York

"Physician-Scientists: Preparation, Opportunities, and National Need"
Kenneth Kaushansky, MD, University of California at San Diego

Biological Scientists in Industry: What Companies Need and Their Criteria for Selection of Professional Scientific Staff"
William T. Schrader, PhD, Schrader Biotech Consulting, Inc

"Building and Supporting Effective Academic Clinical Research Programs in Today's Market-driven Health Care Environment"
Kenneth L. Barker, PhD, Upstate Medical University, New York

"Balancing the Competing Career Demands of the Academic Physician-Scientist: Personal Challenges and Rewards"
Mary Sue O'Dorisio, MD, PhD, University of Iowa

CHAPTER MEETINGS

SEBM regional chapters conduct annual meetings with invited speakers and graduate student abstract presentations.

For additional information, please contact the chapter.